Brighthouse (Nasdaq: BHF) Q1 loss, $4.35 adj EPS and $70 merger deal
Brighthouse Financial reported a first quarter 2026 net loss available to shareholders of $792 million, or $13.82 per diluted share, compared with a net loss of $294 million, or $5.04 per diluted share, a year earlier. The company links this volatility mainly to differences between its hedge targets and GAAP reserving, which are sensitive to market movements.
Non-GAAP performance was steadier. Adjusted earnings were $239 million, or $4.15 per diluted share, versus $235 million, or $4.01, in first quarter 2025, while adjusted earnings, less notable items, were $251 million, or $4.35 per diluted share. Annuity sales were $2.2 billion, largely driven by $1.9 billion of Shield Level Annuities, and life sales were $32 million, both down modestly from prior periods.
Capital and liquidity remained solid. Statutory combined total adjusted capital was $5.0 billion, with an estimated combined risk-based capital ratio between 430% and 450%, at the upper end of the company’s stated target range. Holding company liquid assets totaled $0.9 billion at March 31, 2026.
The release also reiterates a pending all-cash merger. An affiliate of Aquarian Capital LLC has agreed to acquire Brighthouse Financial for $70.00 per share, valuing the transaction at approximately $4.1 billion. Stockholders approved the merger at a special meeting on February 12, 2026, and closing is expected in 2026, subject to customary conditions and regulatory approvals.
Positive
- None.
Negative
- None.
Insights
Large GAAP loss contrasts with stable adjusted earnings and solid capital while a cash buyout progresses.
Brighthouse shows how market-sensitive accounting drives volatility. GAAP net loss available to shareholders was $792 million in Q1 2026, versus a $294 million loss a year earlier, largely reflecting net derivative losses and changes in market risk benefits tied to hedging its variable and indexed annuity guarantees.
Operating profitability was relatively steady. Adjusted earnings were $239 million (up slightly from $235 million in Q1 2025), and adjusted earnings, less notable items, reached $251 million. Annuities generated $2.2 billion of sales, with Shield Level Annuities contributing $1.9 billion. Life sales were modest at $32 million, and the Life segment posted an adjusted loss, highlighting weaker underwriting margins and investment income.
Capital metrics help frame risk. Statutory combined total adjusted capital was $5.0 billion, and the combined risk-based capital ratio was estimated between 430% and 450%, at the upper end of the 400%–450% target range. Holding company liquid assets of $0.9 billion provide additional financial flexibility. In parallel, the planned all-cash acquisition by an Aquarian Capital affiliate at $70.00 per share, valued around $4.1 billion, remains pending after shareholder approval, with completion dependent on insurance regulatory clearances and other customary closing conditions.
8-K Event Classification
Key Figures
Key Terms
adjusted earnings financial
risk-based capital ratio financial
market risk benefits financial
Shield Level Annuities financial
Universal life with secondary guarantees financial
Offering Details

| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of principal executive offices) | (Zip Code) | ||||||||||||||||
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||
Emerging growth company | |||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | ||||||||||
| Exhibit No. | Description | ||||
99.1** | News release of Brighthouse Financial, Inc., dated May 6, 2026, announcing its results for the quarter ended March 31, 2026 | ||||
99.2** | Financial Supplement for the quarter ended March 31, 2026 | ||||
| 104* | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
| BRIGHTHOUSE FINANCIAL, INC. | |||||||||||
| By: | /s/ Melissa B. Pavlovich | ||||||||||
| Name: | Melissa B. Pavlovich | ||||||||||
| Title: | Chief Accounting Officer | ||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| As of or For the Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
| March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total | Per share | Total | Per share | |||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) available to shareholders (1) | $(792) | $(13.82) | $(294) | $(5.04) | ||||||||||||||||||||||||||||||||||||||||||||||
Adjusted earnings (1) | $239 | $4.15 | $235 | $4.01 | ||||||||||||||||||||||||||||||||||||||||||||||
Adjusted earnings, less notable items (1) | $251 | $4.35 | $245 | $4.17 | ||||||||||||||||||||||||||||||||||||||||||||||
Weighted average common shares outstanding - diluted (1) | 57,735,327 | N/A | 58,697,818 | N/A | ||||||||||||||||||||||||||||||||||||||||||||||
| Book value | $3,864 | $67.27 | $3,540 | $61.17 | ||||||||||||||||||||||||||||||||||||||||||||||
| Book value, excluding AOCI | $8,020 | $139.63 | $8,210 | $141.87 | ||||||||||||||||||||||||||||||||||||||||||||||
| Ending common shares outstanding | 57,437,709 | N/A | 57,868,389 | N/A | ||||||||||||||||||||||||||||||||||||||||||||||
(1) Per share amounts are on a diluted basis and may not recalculate due to rounding. See Non-GAAP and Other Financial Disclosures discussion in this news release. | ||||||||||||||||||||||||||||||||||||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| For the Three Months Ended | ||||||||||||||||||||
ADJUSTED EARNINGS (LOSS) (1) | March 31, 2026 | December 31, 2025 | March 31, 2025 | |||||||||||||||||
| Annuities | $324 | $304 | $314 | |||||||||||||||||
Life | $(6) | $18 | $9 | |||||||||||||||||
Run-off | $(48) | $(58) | $(64) | |||||||||||||||||
Corporate & Other | $(31) | $(50) | $(24) | |||||||||||||||||
| (1) The company uses the term "adjusted loss" throughout this news release to refer to negative adjusted earnings values. | ||||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||
| March 31, 2026 | December 31, 2025 | March 31, 2025 | ||||||||||||||||||
| Annuities (1) | $2,178 | $2,734 | $2,259 | |||||||||||||||||
| Life | $32 | $36 | $36 | |||||||||||||||||
| (1) Annuities sales include sales of a fixed index annuity product, which represents 100% of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. Sales of this product were $87 million for the first quarter of 2026, $142 million for the fourth quarter of 2025 and $26 million for the first quarter of 2025. | ||||||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| For the Three Months Ended | ||||||||||||||||||||
| March 31, 2026 | December 31, 2025 | March 31, 2025 | ||||||||||||||||||
| Net investment income | $1,258 | $1,328 | $1,297 | |||||||||||||||||
| Adjusted net investment income | $1,268 | $1,334 | $1,291 | |||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| As of | ||||||||||||||||||||
March 31, 2026 (1) | December 31, 2025 | March 31, 2025 | ||||||||||||||||||
| Statutory combined total adjusted capital | $5.0 | $5.3 | $5.5 | |||||||||||||||||
(1) Reflects preliminary statutory results as of March 31, 2026. | ||||||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
FOR INVESTORS Dana Amante (980) 949-3073 damante@brighthousefinancial.com | FOR MEDIA Meghan Lantier (980) 949-4142 mlantier@brighthousefinancial.com | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| Non-GAAP financial measures: | Most directly comparable GAAP financial measures: | ||||
| adjusted earnings | net income (loss) available to shareholders (1) | ||||
| adjusted earnings, less notable items | net income (loss) available to shareholders (1) | ||||
| adjusted revenues | revenues | ||||
| adjusted expenses | expenses | ||||
| adjusted earnings per common share | earnings per common share, diluted (1) | ||||
| adjusted earnings per common share, less notable items | earnings per common share, diluted (1) | ||||
| adjusted return on common equity | return on common equity (2) | ||||
| adjusted return on common equity, less notable items | return on common equity (2) | ||||
| adjusted net investment income | net investment income | ||||
| adjusted net investment income yield | net investment income yield | ||||
__________________ | |||||
(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.'s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share. | |||||
| (2) Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.'s common stockholders' equity. | |||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| For the Three Months Ended | ||||||||||||||||||||
| Revenues | March 31, 2026 | December 31, 2025 | March 31, 2025 | |||||||||||||||||
| Premiums | $168 | $173 | $186 | |||||||||||||||||
| Universal life and investment-type product policy fees | 533 | 534 | 543 | |||||||||||||||||
| Net investment income | 1,258 | 1,328 | 1,297 | |||||||||||||||||
| Other revenues | 129 | 133 | 136 | |||||||||||||||||
| Revenues before NIGL and NDGL | 2,088 | 2,168 | 2,162 | |||||||||||||||||
| Net investment gains (losses) | (52) | (23) | (83) | |||||||||||||||||
| Net derivative gains (losses) | (509) | (456) | 311 | |||||||||||||||||
| Total revenues | $1,527 | $1,689 | $2,390 | |||||||||||||||||
| Expenses | ||||||||||||||||||||
| Policyholder benefits and claims | $637 | $697 | $649 | |||||||||||||||||
| Interest credited to policyholder account balances | 493 | 529 | 561 | |||||||||||||||||
| Amortization of DAC and VOBA | 158 | 159 | 148 | |||||||||||||||||
| Change in market risk benefits | 748 | (349) | 893 | |||||||||||||||||
| Interest expense on debt | 38 | 38 | 38 | |||||||||||||||||
| Other expenses | 439 | 465 | 455 | |||||||||||||||||
| Total expenses | 2,513 | 1,539 | 2,744 | |||||||||||||||||
| Income (loss) before provision for income tax | (986) | 150 | (354) | |||||||||||||||||
| Provision for income tax expense (benefit) | (222) | 12 | (88) | |||||||||||||||||
| Net income (loss) | (764) | 138 | (266) | |||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | 2 | 1 | 2 | |||||||||||||||||
| Net income (loss) attributable to Brighthouse Financial, Inc. | (766) | 137 | (268) | |||||||||||||||||
| Less: Preferred stock dividends | 26 | 25 | 26 | |||||||||||||||||
| Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $(792) | $112 | $(294) | |||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| As of | ||||||||||||||||||||
| ASSETS | March 31, 2026 | December 31, 2025 | March 31, 2025 | |||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturity securities available-for-sale | $81,232 | $82,014 | $80,640 | |||||||||||||||||
| Trading securities | 544 | 506 | 365 | |||||||||||||||||
| Equity securities | 76 | 79 | 73 | |||||||||||||||||
| Mortgage loans | 22,620 | 22,755 | 23,051 | |||||||||||||||||
| Policy loans | 1,458 | 1,450 | 1,436 | |||||||||||||||||
| Limited partnerships and limited liability companies | 4,673 | 4,696 | 4,839 | |||||||||||||||||
| Short-term investments | 1,236 | 1,197 | 1,569 | |||||||||||||||||
| Other invested assets | 9,617 | 7,932 | 5,284 | |||||||||||||||||
| Total investments | 121,456 | 120,629 | 117,257 | |||||||||||||||||
| Cash and cash equivalents | 4,907 | 5,387 | 4,667 | |||||||||||||||||
| Accrued investment income | 1,302 | 1,260 | 1,267 | |||||||||||||||||
| Reinsurance recoverables | 20,313 | 20,903 | 20,454 | |||||||||||||||||
| Premiums and other receivables | 513 | 676 | 734 | |||||||||||||||||
| DAC and VOBA | 4,520 | 4,567 | 4,672 | |||||||||||||||||
| Current income tax recoverable | 16 | 16 | 20 | |||||||||||||||||
| Deferred income tax asset | 1,781 | 1,442 | 1,808 | |||||||||||||||||
| Market risk benefit assets | 850 | 1,060 | 914 | |||||||||||||||||
| Other assets | 324 | 332 | 364 | |||||||||||||||||
| Separate account assets | 80,821 | 85,528 | 82,524 | |||||||||||||||||
| Total assets | $236,803 | $241,800 | $234,681 | |||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Future policy benefits | $31,773 | $32,025 | $31,834 | |||||||||||||||||
| Policyholder account balances | 86,379 | 87,952 | 85,618 | |||||||||||||||||
| Market risk benefit liabilities | 8,564 | 8,063 | 9,165 | |||||||||||||||||
| Other policy-related balances | 3,994 | 3,893 | 3,866 | |||||||||||||||||
| Payables for collateral under securities loaned and other transactions | 4,661 | 4,705 | 3,904 | |||||||||||||||||
| Long-term debt | 3,154 | 3,155 | 3,155 | |||||||||||||||||
| Other liabilities | 11,829 | 9,646 | 9,311 | |||||||||||||||||
| Separate account liabilities | 80,821 | 85,528 | 82,524 | |||||||||||||||||
| Total liabilities | 231,175 | 234,967 | 229,377 | |||||||||||||||||
| Equity | ||||||||||||||||||||
| Preferred stock, at par value | — | — | — | |||||||||||||||||
| Common stock, at par value | 1 | 1 | 1 | |||||||||||||||||
| Additional paid-in capital | 13,869 | 13,870 | 13,939 | |||||||||||||||||
| Retained earnings (deficit) | (1,452) | (686) | (1,387) | |||||||||||||||||
| Treasury stock | (2,699) | (2,688) | (2,644) | |||||||||||||||||
| Accumulated other comprehensive income (loss) | (4,156) | (3,729) | (4,670) | |||||||||||||||||
| Total Brighthouse Financial, Inc.’s stockholders’ equity | 5,563 | 6,768 | 5,239 | |||||||||||||||||
| Noncontrolling interests | 65 | 65 | 65 | |||||||||||||||||
| Total equity | 5,628 | 6,833 | 5,304 | |||||||||||||||||
| Total liabilities and equity | $236,803 | $241,800 | $234,681 | |||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS | March 31, 2026 | December 31, 2025 | March 31, 2025 | |||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders | $(792) | $112 | $(294) | |||||||||||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (52) | (23) | (83) | |||||||||||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (10) | (7) | 6 | |||||||||||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | (509) | (455) | 311 | |||||||||||||||||||||||||||||||||||
| Less: Change in market risk benefits | (748) | 349 | (893) | |||||||||||||||||||||||||||||||||||
| Less: Market value adjustments | 13 | 6 | (10) | |||||||||||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | 275 | 28 | 140 | |||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) | 239 | 214 | 235 | |||||||||||||||||||||||||||||||||||
| Less: Notable items | (12) | (13) | (10) | |||||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items | $251 | $227 | $245 | |||||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS, PER COMMON SHARE (1) | ||||||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders per common share | $(13.82) | $1.93 | $(5.04) | |||||||||||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (0.91) | (0.40) | (1.42) | |||||||||||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (0.17) | (0.12) | 0.10 | |||||||||||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | (8.88) | (7.87) | 5.34 | |||||||||||||||||||||||||||||||||||
| Less: Change in market risk benefits | (13.05) | 6.04 | (15.33) | |||||||||||||||||||||||||||||||||||
| Less: Market value adjustments | 0.23 | 0.10 | (0.17) | |||||||||||||||||||||||||||||||||||
| Less: Provision for income tax (expense) benefit on reconciling adjustments | 4.80 | 0.48 | 2.40 | |||||||||||||||||||||||||||||||||||
| Less: Impact of inclusion of dilutive shares | 0.03 | — | 0.03 | |||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) per common share | 4.15 | 3.70 | 4.01 | |||||||||||||||||||||||||||||||||||
| Less: Notable items | (0.21) | (0.22) | (0.17) | |||||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items per common share | $4.35 | $3.93 | $4.17 | |||||||||||||||||||||||||||||||||||
(1) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. See Non-GAAP and Other Financial Disclosures discussion in this news release. | ||||||||||||||||||||||||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
ADJUSTED NET INVESTMENT INCOME (1) | March 31, 2026 | December 31, 2025 | March 31, 2025 | |||||||||||||||||||||||||||||
| Net investment income | $1,258 | $1,328 | $1,297 | |||||||||||||||||||||||||||||
Add: Investment hedge adjustments | — | (1) | — | |||||||||||||||||||||||||||||
Less: Investment gains (losses) on trading securities | (10) | (7) | 6 | |||||||||||||||||||||||||||||
| Adjusted net investment income | $1,268 | $1,334 | $1,291 | |||||||||||||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| ADJUSTED NET INVESTMENT INCOME YIELD (1) | March 31, 2026 | December 31, 2025 | March 31, 2025 | |||||||||||||||||||||||||||||
| Investment income yield | 4.39% | 4.60% | 4.39% | |||||||||||||||||||||||||||||
| Investment fees and expenses | (0.15)% | (0.16)% | (0.14)% | |||||||||||||||||||||||||||||
| Adjusted net investment income yield | 4.24% | 4.44% | 4.25% | |||||||||||||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS | March 31, 2026 | December 31, 2025 | March 31, 2025 | |||||||||||||||||||||||||||||
| Actuarial items and other insurance adjustments | $12 | $13 | $10 | |||||||||||||||||||||||||||||
| Total notable items (1) | $12 | $13 | $10 | |||||||||||||||||||||||||||||
NOTABLE ITEMS BY SEGMENT | ||||||||||||||||||||||||||||||||
| Annuities | $— | $— | $10 | |||||||||||||||||||||||||||||
| Life | (5) | 6 | — | |||||||||||||||||||||||||||||
| Run-off | 17 | 7 | — | |||||||||||||||||||||||||||||
| Corporate & Other | — | — | — | |||||||||||||||||||||||||||||
| Total notable items (1) | $12 | $13 | $10 | |||||||||||||||||||||||||||||
| (1) See Non-GAAP and Other Financial Disclosures discussion in this news release. | ||||||||||||||||||||||||||||||||
| Table of Contents | Financial Results | |||||||
1 | Key Metrics | |||||||
2 | GAAP Statements of Operations | |||||||
3 | GAAP Balance Sheets | |||||||
Earnings and Select Metrics from Segments | ||||||||
5 | Statements of Adjusted Earnings by Segment | |||||||
6 | Annuities — Statements of Adjusted Earnings | |||||||
7 | Annuities — Select Operating Metrics | |||||||
9 | Life — Statements of Adjusted Earnings | |||||||
10 | Life — Select Operating Metrics | |||||||
12 | Run-off — Statements of Adjusted Earnings | |||||||
13 | Run-off — Select Operating Metrics | |||||||
14 | Corporate & Other — Statements of Adjusted Earnings and Select Operating Metrics | |||||||
| Other Information | ||||||||
16 | Change in Market Risk Benefits and Net Derivative Gains (Losses) | |||||||
17 | Notable Items | |||||||
18 | Variable Annuity Separate Account Returns and Allocations | |||||||
19 | Summary of Investments | |||||||
20 | Statutory Statement of Operations Information | |||||||
21 | Statutory Balance Sheet and Surplus Information | |||||||
| Appendix | ||||||||
A-1 | Note Regarding Forward-Looking Statements | |||||||
A-2 | Non-GAAP and Other Financial Disclosures | |||||||
A-6 | Acronyms | |||||||
A-7 | Reconciliation of Net Income (Loss) Available to Shareholders to Adjusted Earnings (Loss) and Adjusted Earnings, Less Notable Items, and Reconciliation of Net Income (Loss) Available to Shareholders per Common Share to Adjusted Earnings (Loss) per Common Share and Adjusted Earnings, Less Notable Items per Common Share | |||||||
A-8 | Reconciliation of Return on Common Equity to Adjusted Return on Common Equity, Excluding AOCI | |||||||
A-9 | Reconciliation of Total Revenues to Adjusted Revenues and Reconciliation of Total Expenses to Adjusted Expenses | |||||||
A-10 | Investment Reconciliation Details | |||||||


| Financial Supplement | 1 | |||||||||||||
| As of or For the Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
| Financial Results and Metrics (1) | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders | $(792) | $112 | $453 | $60 | $(294) | |||||||||||||||||||||||||||||||||||||||
Adjusted earnings (2) | $239 | $214 | $970 | $198 | $235 | |||||||||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items (2) | $251 | $227 | $261 | $198 | $245 | |||||||||||||||||||||||||||||||||||||||
| Total corporate expenses (3) | $227 | $234 | $205 | $202 | $239 | |||||||||||||||||||||||||||||||||||||||
Combined total adjusted capital (4) | $5,000 | $5,328 | $5,400 | $5,560 | $5,549 | |||||||||||||||||||||||||||||||||||||||
Combined risk-based capital ratio (4), (5) | 430%-450% | 456% | 435%-455% | 405%-425% | 420%-440% | |||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s stockholders’ equity | $5,563 | $6,768 | $6,363 | $5,673 | $5,239 | |||||||||||||||||||||||||||||||||||||||
| Less: Preferred stock, net | 1,699 | 1,699 | 1,699 | 1,699 | 1,699 | |||||||||||||||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s common stockholders’ equity, including AOCI | $3,864 | $5,069 | $4,664 | $3,974 | $3,540 | |||||||||||||||||||||||||||||||||||||||
| Less: AOCI | (4,156) | (3,729) | (4,020) | (4,257) | (4,670) | |||||||||||||||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI | $8,020 | $8,798 | $8,684 | $8,231 | $8,210 | |||||||||||||||||||||||||||||||||||||||
Return on Common Equity (1) | ||||||||||||||||||||||||||||||||||||||||||||
| Return on common equity | (4.0)% | 8.1% | 22.5% | 16.5% | 16.4% | |||||||||||||||||||||||||||||||||||||||
| Return on common equity, excluding AOCI | (2.0)% | 3.9% | 10.4% | 6.9% | 6.3% | |||||||||||||||||||||||||||||||||||||||
| Adjusted return on common equity, excluding AOCI | 19.3% | 19.0% | 20.5% | 18.4% | 20.4% | |||||||||||||||||||||||||||||||||||||||
Earnings Per Common Share, Diluted (1), (6) | ||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders per common share | $(13.82) | $1.93 | $7.89 | $1.02 | $(5.04) | |||||||||||||||||||||||||||||||||||||||
| Adjusted earnings per common share | $4.15 | $3.70 | $16.87 | $3.43 | $4.01 | |||||||||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items per common share | $4.35 | $3.93 | $4.54 | $3.43 | $4.17 | |||||||||||||||||||||||||||||||||||||||
| Weighted average common shares outstanding | 57,735,327 | 57,829,186 | 57,512,901 | 57,734,170 | 58,697,818 | |||||||||||||||||||||||||||||||||||||||
| Book Value Per Common Share | ||||||||||||||||||||||||||||||||||||||||||||
| Book value per common share (1) | $67.27 | $88.66 | $81.60 | $69.57 | $61.17 | |||||||||||||||||||||||||||||||||||||||
| Book value per common share, excluding AOCI (1) | $139.63 | $153.89 | $151.94 | $144.09 | $141.87 | |||||||||||||||||||||||||||||||||||||||
| Ending common shares outstanding | 57,437,709 | 57,171,217 | 57,153,571 | 57,122,494 | 57,868,389 | |||||||||||||||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||||||||
| (2) See additional information regarding notable items on page 17. | ||||||||||||||||||||||||||||||||||||||||||||
| (3) Includes functional department expenses, public company expenses, certain investment expenses, retirement funding and incentive compensation. Beginning in 2026, corporate expenses exclude certain transaction-related costs. Corporate expenses excluding certain transaction-related costs were $219 million, $200 million, $195 million and $234 million for the three months ended December 31, 2025, September 30, 2025, June 30, 2025 and March 31, 2025, respectively. | ||||||||||||||||||||||||||||||||||||||||||||
(4) Reflects preliminary statutory results as of or for the three months ended March 31, 2026. See additional information on page 21. | ||||||||||||||||||||||||||||||||||||||||||||
(5) The RBC ratio is reported as a preliminary range for all periods, except those ended December 31. | ||||||||||||||||||||||||||||||||||||||||||||
(6) For loss periods, dilutive shares were not included in the calculation of net income (loss) available to shareholders per common share or adjusted earnings (loss) per common share as inclusion of such shares would have an anti-dilutive effect. | ||||||||||||||||||||||||||||||||||||||||||||

| Financial Supplement | 2 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| Revenues | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Premiums | $168 | $173 | $170 | $166 | $186 | $168 | $186 | |||||||||||||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 533 | 534 | 531 | 553 | 543 | 533 | 543 | |||||||||||||||||||||||||||||||||||||
| Net investment income | 1,258 | 1,328 | 1,334 | 1,285 | 1,297 | 1,258 | 1,297 | |||||||||||||||||||||||||||||||||||||
| Other revenues | 129 | 133 | 143 | 143 | 136 | 129 | 136 | |||||||||||||||||||||||||||||||||||||
| Revenues before NIGL and NDGL | 2,088 | 2,168 | 2,178 | 2,147 | 2,162 | 2,088 | 2,162 | |||||||||||||||||||||||||||||||||||||
| Net investment gains (losses) | (52) | (23) | 48 | (39) | (83) | (52) | (83) | |||||||||||||||||||||||||||||||||||||
| Net derivative gains (losses) | (509) | (456) | (410) | (1,237) | 311 | (509) | 311 | |||||||||||||||||||||||||||||||||||||
| Total revenues | $1,527 | $1,689 | $1,816 | $871 | $2,390 | $1,527 | $2,390 | |||||||||||||||||||||||||||||||||||||
| Expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $637 | $697 | $(252) | $711 | $649 | $637 | $649 | |||||||||||||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 493 | 529 | 561 | 537 | 561 | 493 | 561 | |||||||||||||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 158 | 159 | 153 | 149 | 148 | 158 | 148 | |||||||||||||||||||||||||||||||||||||
| Change in market risk benefits | 748 | (349) | 289 | (1,101) | 893 | 748 | 893 | |||||||||||||||||||||||||||||||||||||
| Interest expense on debt | 38 | 38 | 38 | 38 | 38 | 38 | 38 | |||||||||||||||||||||||||||||||||||||
| Other expenses | 439 | 465 | 442 | 444 | 455 | 439 | 455 | |||||||||||||||||||||||||||||||||||||
| Total expenses | 2,513 | 1,539 | 1,231 | 778 | 2,744 | 2,513 | 2,744 | |||||||||||||||||||||||||||||||||||||
| Income (loss) before provision for income tax | (986) | 150 | 585 | 93 | (354) | (986) | (354) | |||||||||||||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | (222) | 12 | 104 | 8 | (88) | (222) | (88) | |||||||||||||||||||||||||||||||||||||
| Net income (loss) | (764) | 138 | 481 | 85 | (266) | (764) | (266) | |||||||||||||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | 2 | 1 | 2 | — | 2 | 2 | 2 | |||||||||||||||||||||||||||||||||||||
| Net income (loss) attributable to Brighthouse Financial, Inc. | (766) | 137 | 479 | 85 | (268) | (766) | (268) | |||||||||||||||||||||||||||||||||||||
| Less: Preferred stock dividends | 26 | 25 | 26 | 25 | 26 | 26 | 26 | |||||||||||||||||||||||||||||||||||||
| Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $(792) | $112 | $453 | $60 | $(294) | $(792) | $(294) | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | 3 | |||||||||||||
| As of | ||||||||||||||||||||||||||||||||
| ASSETS | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Investments: | ||||||||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale | $81,232 | $82,014 | $81,537 | $80,835 | $80,640 | |||||||||||||||||||||||||||
| Trading securities | 544 | 506 | 528 | 520 | 365 | |||||||||||||||||||||||||||
| Equity securities | 76 | 79 | 78 | 74 | 73 | |||||||||||||||||||||||||||
| Mortgage loans | 22,620 | 22,755 | 22,862 | 22,993 | 23,051 | |||||||||||||||||||||||||||
| Policy loans | 1,458 | 1,450 | 1,439 | 1,425 | 1,436 | |||||||||||||||||||||||||||
| Limited partnerships and limited liability companies | 4,673 | 4,696 | 4,816 | 4,798 | 4,839 | |||||||||||||||||||||||||||
| Short-term investments | 1,236 | 1,197 | 778 | 1,170 | 1,569 | |||||||||||||||||||||||||||
| Other invested assets | 9,617 | 7,932 | 8,842 | 8,932 | 5,284 | |||||||||||||||||||||||||||
| Total investments | 121,456 | 120,629 | 120,880 | 120,747 | 117,257 | |||||||||||||||||||||||||||
| Cash and cash equivalents | 4,907 | 5,387 | 6,606 | 5,540 | 4,667 | |||||||||||||||||||||||||||
| Accrued investment income | 1,302 | 1,260 | 1,350 | 1,235 | 1,267 | |||||||||||||||||||||||||||
| Reinsurance recoverables | 20,313 | 20,903 | 20,400 | 20,701 | 20,454 | |||||||||||||||||||||||||||
| Premiums and other receivables | 513 | 676 | 844 | 557 | 734 | |||||||||||||||||||||||||||
| DAC and VOBA | 4,520 | 4,567 | 4,603 | 4,636 | 4,672 | |||||||||||||||||||||||||||
| Current income tax recoverable | 16 | 16 | 17 | 17 | 20 | |||||||||||||||||||||||||||
| Deferred income tax asset | 1,781 | 1,442 | 1,531 | 1,695 | 1,808 | |||||||||||||||||||||||||||
| Market risk benefit assets | 850 | 1,060 | 979 | 1,084 | 914 | |||||||||||||||||||||||||||
| Other assets | 324 | 332 | 342 | 348 | 364 | |||||||||||||||||||||||||||
| Separate account assets | 80,821 | 85,528 | 87,127 | 86,085 | 82,524 | |||||||||||||||||||||||||||
| Total assets | $236,803 | $241,800 | $244,679 | $242,645 | $234,681 | |||||||||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||||||||
| Future policy benefits | $31,773 | $32,025 | $32,021 | $31,974 | $31,834 | |||||||||||||||||||||||||||
| Policyholder account balances | 86,379 | 87,952 | 88,703 | 88,046 | 85,618 | |||||||||||||||||||||||||||
| Market risk benefit liabilities | 8,564 | 8,063 | 8,529 | 8,051 | 9,165 | |||||||||||||||||||||||||||
| Other policy-related balances | 3,994 | 3,893 | 3,918 | 3,977 | 3,866 | |||||||||||||||||||||||||||
| Payables for collateral under securities loaned and other transactions | 4,661 | 4,705 | 4,347 | 3,994 | 3,904 | |||||||||||||||||||||||||||
| Long-term debt | 3,154 | 3,155 | 3,155 | 3,155 | 3,155 | |||||||||||||||||||||||||||
| Other liabilities | 11,829 | 9,646 | 10,451 | 11,625 | 9,311 | |||||||||||||||||||||||||||
| Separate account liabilities | 80,821 | 85,528 | 87,127 | 86,085 | 82,524 | |||||||||||||||||||||||||||
| Total liabilities | 231,175 | 234,967 | 238,251 | 236,907 | 229,377 | |||||||||||||||||||||||||||
| Equity | ||||||||||||||||||||||||||||||||
| Preferred stock, at par value | — | — | — | — | — | |||||||||||||||||||||||||||
| Common stock, at par value | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||||||
| Additional paid-in capital | 13,869 | 13,870 | 13,893 | 13,918 | 13,939 | |||||||||||||||||||||||||||
| Retained earnings (deficit) | (1,452) | (686) | (823) | (1,302) | (1,387) | |||||||||||||||||||||||||||
| Treasury stock | (2,699) | (2,688) | (2,688) | (2,687) | (2,644) | |||||||||||||||||||||||||||
| Accumulated other comprehensive income (loss) | (4,156) | (3,729) | (4,020) | (4,257) | (4,670) | |||||||||||||||||||||||||||
| Total Brighthouse Financial, Inc.’s stockholders’ equity | 5,563 | 6,768 | 6,363 | 5,673 | 5,239 | |||||||||||||||||||||||||||
| Noncontrolling interests | 65 | 65 | 65 | 65 | 65 | |||||||||||||||||||||||||||
| Total equity | 5,628 | 6,833 | 6,428 | 5,738 | 5,304 | |||||||||||||||||||||||||||
| Total liabilities and equity | $236,803 | $241,800 | $244,679 | $242,645 | $234,681 | |||||||||||||||||||||||||||


| Financial Supplement | 5 | |||||||||||||
| For the Three Months Ended March 31, 2026 | ||||||||||||||||||||||||||||||||
| Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
| Premiums | $79 | $89 | $— | $— | $168 | |||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 388 | 57 | 88 | — | 533 | |||||||||||||||||||||||||||
| Net investment income | 771 | 98 | 268 | 131 | 1,268 | |||||||||||||||||||||||||||
| Other revenues | 117 | 4 | 7 | 1 | 129 | |||||||||||||||||||||||||||
| Total adjusted revenues | $1,355 | $248 | $363 | $132 | $2,098 | |||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $124 | $170 | $343 | $— | $637 | |||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 334 | 29 | 53 | 90 | 506 | |||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 137 | 21 | — | — | 158 | |||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | 38 | 38 | |||||||||||||||||||||||||||
| Other operating costs | 360 | 36 | 28 | 15 | 439 | |||||||||||||||||||||||||||
| Total adjusted expenses | 955 | 256 | 424 | 143 | 1,778 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) before provision for income tax | 400 | (8) | (61) | (11) | 320 | |||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | 76 | (2) | (13) | (8) | 53 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) after provision for income tax | 324 | (6) | (48) | (3) | 267 | |||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | — | — | — | 2 | 2 | |||||||||||||||||||||||||||
| Less: Preferred stock dividends | — | — | — | 26 | 26 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) | $324 | $(6) | $(48) | $(31) | $239 | |||||||||||||||||||||||||||
| For the Three Months Ended March 31, 2025 | ||||||||||||||||||||||||||||||||
| Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
| Premiums | $65 | $121 | $— | $— | $186 | |||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 396 | 59 | 88 | — | 543 | |||||||||||||||||||||||||||
| Net investment income | 753 | 107 | 272 | 159 | 1,291 | |||||||||||||||||||||||||||
| Other revenues | 130 | 4 | 7 | (5) | 136 | |||||||||||||||||||||||||||
| Total adjusted revenues | $1,344 | $291 | $367 | $154 | $2,156 | |||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $110 | $187 | $352 | $— | $649 | |||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 358 | 27 | 60 | 106 | 551 | |||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 126 | 22 | — | — | 148 | |||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | 38 | 38 | |||||||||||||||||||||||||||
| Other operating costs | 363 | 45 | 36 | 11 | 455 | |||||||||||||||||||||||||||
| Total adjusted expenses | 957 | 281 | 448 | 155 | 1,841 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) before provision for income tax | 387 | 10 | (81) | (1) | 315 | |||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | 73 | 1 | (17) | (5) | 52 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) after provision for income tax | 314 | 9 | (64) | 4 | 263 | |||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | — | — | — | 2 | 2 | |||||||||||||||||||||||||||
| Less: Preferred stock dividends | — | — | — | 26 | 26 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) | $314 | $9 | $(64) | $(24) | $235 | |||||||||||||||||||||||||||

| Financial Supplement | 6 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| Adjusted revenues | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Premiums | $79 | $72 | $68 | $60 | $65 | $79 | $65 | |||||||||||||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 388 | 364 | 372 | 385 | 396 | 388 | 396 | |||||||||||||||||||||||||||||||||||||
| Net investment income | 771 | 776 | 770 | 757 | 753 | 771 | 753 | |||||||||||||||||||||||||||||||||||||
| Other revenues | 117 | 122 | 126 | 129 | 130 | 117 | 130 | |||||||||||||||||||||||||||||||||||||
| Total adjusted revenues | $1,355 | $1,334 | $1,336 | $1,331 | $1,344 | $1,355 | $1,344 | |||||||||||||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $124 | $123 | $125 | $98 | $110 | $124 | $110 | |||||||||||||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 334 | 352 | 357 | 354 | 358 | 334 | 358 | |||||||||||||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 137 | 138 | 131 | 127 | 126 | 137 | 126 | |||||||||||||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Other operating costs | 360 | 344 | 348 | 342 | 363 | 360 | 363 | |||||||||||||||||||||||||||||||||||||
| Total adjusted expenses | 955 | 957 | 961 | 921 | 957 | 955 | 957 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings before provision for income tax | 400 | 377 | 375 | 410 | 387 | 400 | 387 | |||||||||||||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | 76 | 73 | 71 | 78 | 73 | 76 | 73 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings | $324 | $304 | $304 | $332 | $314 | $324 | $314 | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | 7 | |||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| VARIABLE AND SHIELD LEVEL ANNUITIES ACCOUNT VALUE (1) | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Account value, beginning of period | $129,906 | $130,470 | $127,180 | $120,963 | $125,121 | |||||||||||||||||||||||||||
| Premiums and deposits (2) | 2,109 | 2,342 | 2,309 | 2,188 | 2,201 | |||||||||||||||||||||||||||
| Withdrawals, surrenders and contract benefits | (4,670) | (5,009) | (4,594) | (4,190) | (4,156) | |||||||||||||||||||||||||||
| Net flows (3) | (2,561) | (2,667) | (2,285) | (2,002) | (1,955) | |||||||||||||||||||||||||||
| Investment performance (4) | (2,650) | 2,621 | 6,129 | 8,758 | (1,715) | |||||||||||||||||||||||||||
| Policy charges and other | (467) | (518) | (554) | (539) | (488) | |||||||||||||||||||||||||||
| Account value, end of period | $124,228 | $129,906 | $130,470 | $127,180 | $120,963 | |||||||||||||||||||||||||||
| FIXED ANNUITIES ACCOUNT VALUE (5) | ||||||||||||||||||||||||||||||||
| Account value, beginning of period | $17,820 | $18,456 | $19,339 | $19,355 | $19,577 | |||||||||||||||||||||||||||
| Premiums and deposits (2) | 144 | 469 | 506 | 504 | 131 | |||||||||||||||||||||||||||
| Withdrawals, surrenders and contract benefits | (755) | (1,277) | (1,615) | (688) | (562) | |||||||||||||||||||||||||||
| Net flows (3) | (611) | (808) | (1,109) | (184) | (431) | |||||||||||||||||||||||||||
| Interest credited | 159 | 164 | 170 | 169 | 168 | |||||||||||||||||||||||||||
| Other | 36 | 8 | 56 | (1) | 41 | |||||||||||||||||||||||||||
| Account value, end of period | $17,404 | $17,820 | $18,456 | $19,339 | $19,355 | |||||||||||||||||||||||||||
INSTITUTIONAL GROUP ANNUITIES ACCOUNT VALUE (1) | ||||||||||||||||||||||||||||||||
Institutional group annuities account value, end of period | $595 | $569 | $584 | $566 | $401 | |||||||||||||||||||||||||||
| INCOME ANNUITIES (1) | ||||||||||||||||||||||||||||||||
| Income annuity insurance liabilities, end of period | $4,750 | $4,788 | $4,755 | $4,645 | $4,583 | |||||||||||||||||||||||||||
| (1) Includes general account and separate account. | ||||||||||||||||||||||||||||||||
| (2) Includes premiums and deposits directed to the general account investment option of variable products. | ||||||||||||||||||||||||||||||||
| (3) Deposits and withdrawals include policy exchanges. | ||||||||||||||||||||||||||||||||
| (4) Includes the interest credited on the general account option of variable products. | ||||||||||||||||||||||||||||||||
| (5) Includes fixed index annuities. | ||||||||||||||||||||||||||||||||

| Financial Supplement | 8 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| VARIABLE AND SHIELD LEVEL ANNUITY SALES | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Shield Level Annuities (1) | $1,868 | $2,074 | $2,052 | $1,925 | $1,957 | $1,868 | $1,957 | |||||||||||||||||||||||||||||||||||||
| GMWB | 107 | 118 | 115 | 109 | 103 | 107 | 103 | |||||||||||||||||||||||||||||||||||||
| GMDB only | 55 | 69 | 55 | 67 | 58 | 55 | 58 | |||||||||||||||||||||||||||||||||||||
| GMIB | 3 | 2 | 3 | 4 | 4 | 3 | 4 | |||||||||||||||||||||||||||||||||||||
| Total variable and Shield Level annuity sales | $2,033 | $2,263 | $2,225 | $2,105 | $2,122 | $2,033 | $2,122 | |||||||||||||||||||||||||||||||||||||
| FIXED AND INCOME ANNUITY SALES | ||||||||||||||||||||||||||||||||||||||||||||
| Fixed index annuities (2) | $87 | $142 | $126 | $89 | $26 | $87 | $26 | |||||||||||||||||||||||||||||||||||||
| Fixed deferred annuities | 55 | 324 | 377 | 412 | 103 | 55 | 103 | |||||||||||||||||||||||||||||||||||||
| Single premium immediate annuities | 2 | 2 | 1 | 2 | 5 | 2 | 5 | |||||||||||||||||||||||||||||||||||||
| Other fixed and income annuities | 1 | 3 | 2 | 2 | 3 | 1 | 3 | |||||||||||||||||||||||||||||||||||||
| Total fixed and income annuity sales | $145 | $471 | $506 | $505 | $137 | $145 | $137 | |||||||||||||||||||||||||||||||||||||
| (1) Shield Level Annuities refers to our suite of structured annuities consisting of products marketed under various names. | ||||||||||||||||||||||||||||||||||||||||||||
| (2) Represents 100% of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. | ||||||||||||||||||||||||||||||||||||||||||||

| Financial Supplement | 9 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| Adjusted revenues | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Premiums | $89 | $101 | $102 | $104 | $121 | $89 | $121 | |||||||||||||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 57 | 83 | 74 | 78 | 59 | 57 | 59 | |||||||||||||||||||||||||||||||||||||
| Net investment income | 98 | 111 | 117 | 97 | 107 | 98 | 107 | |||||||||||||||||||||||||||||||||||||
| Other revenues | 4 | 3 | 4 | 4 | 4 | 4 | 4 | |||||||||||||||||||||||||||||||||||||
| Total adjusted revenues | $248 | $298 | $297 | $283 | $291 | $248 | $291 | |||||||||||||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $170 | $182 | $142 | $213 | $187 | $170 | $187 | |||||||||||||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 29 | 30 | 30 | 28 | 27 | 29 | 27 | |||||||||||||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 21 | 21 | 22 | 22 | 22 | 21 | 22 | |||||||||||||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Other operating costs | 36 | 46 | 54 | 53 | 45 | 36 | 45 | |||||||||||||||||||||||||||||||||||||
| Total adjusted expenses | 256 | 279 | 248 | 316 | 281 | 256 | 281 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) before provision for income tax | (8) | 19 | 49 | (33) | 10 | (8) | 10 | |||||||||||||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | (2) | 1 | 9 | (7) | 1 | (2) | 1 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) | $(6) | $18 | $40 | $(26) | $9 | $(6) | $9 | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | 10 | |||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| LIFE ACCOUNT VALUE: GENERAL ACCOUNT | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Universal and variable universal life account value, beginning of period | $2,627 | $2,615 | $2,605 | $2,597 | $2,590 | |||||||||||||||||||||||||||
| Premiums and deposits (1) | 61 | 66 | 65 | 62 | 69 | |||||||||||||||||||||||||||
| Withdrawals, surrenders and contract benefits | (33) | (38) | (36) | (41) | (46) | |||||||||||||||||||||||||||
| Net flows | 28 | 28 | 29 | 21 | 23 | |||||||||||||||||||||||||||
| Net transfers from (to) separate account | 8 | 10 | 12 | 8 | 10 | |||||||||||||||||||||||||||
| Interest credited | 27 | 29 | 29 | 26 | 27 | |||||||||||||||||||||||||||
| Policy charges and other | (61) | (55) | (60) | (47) | (53) | |||||||||||||||||||||||||||
| Universal and variable universal life account value, end of period | $2,629 | $2,627 | $2,615 | $2,605 | $2,597 | |||||||||||||||||||||||||||
| LIFE ACCOUNT VALUE: SEPARATE ACCOUNT | ||||||||||||||||||||||||||||||||
| Variable universal life account value, beginning of period | $6,860 | $6,859 | $6,632 | $6,125 | $6,419 | |||||||||||||||||||||||||||
| Premiums and deposits | 34 | 35 | 34 | 36 | 38 | |||||||||||||||||||||||||||
| Withdrawals, surrenders and contract benefits | (87) | (83) | (89) | (71) | (92) | |||||||||||||||||||||||||||
| Net flows | (53) | (48) | (55) | (35) | (54) | |||||||||||||||||||||||||||
| Investment performance | (249) | 118 | 341 | 605 | (180) | |||||||||||||||||||||||||||
| Net transfers from (to) general account | (8) | (10) | (12) | (8) | (10) | |||||||||||||||||||||||||||
| Policy charges and other | (53) | (59) | (47) | (55) | (50) | |||||||||||||||||||||||||||
| Variable universal life account value, end of period | $6,497 | $6,860 | $6,859 | $6,632 | $6,125 | |||||||||||||||||||||||||||
| (1) Includes premiums and deposits directed to the general account investment option of variable products. | ||||||||||||||||||||||||||||||||

| Financial Supplement | 11 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| LIFE SALES | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Total life sales | $32 | $36 | $38 | $33 | $36 | $32 | $36 | |||||||||||||||||||||||||||||||||||||
| As of | ||||||||||||||||||||||||||||||||
| LIFE INSURANCE IN-FORCE | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Whole Life | ||||||||||||||||||||||||||||||||
| Life Insurance in-force, before reinsurance | $15,931 | $16,098 | $16,280 | $16,441 | $16,666 | |||||||||||||||||||||||||||
| Life Insurance in-force, net of reinsurance | $2,737 | $2,761 | $2,799 | $2,818 | $2,855 | |||||||||||||||||||||||||||
| Term Life | ||||||||||||||||||||||||||||||||
| Life Insurance in-force, before reinsurance | $306,263 | $312,477 | $319,061 | $325,210 | $331,301 | |||||||||||||||||||||||||||
| Life Insurance in-force, net of reinsurance | $253,538 | $258,169 | $263,178 | $267,845 | $272,711 | |||||||||||||||||||||||||||
| Universal and Variable Universal Life | ||||||||||||||||||||||||||||||||
| Life Insurance in-force, before reinsurance | $40,235 | $41,053 | $41,500 | $41,726 | $41,735 | |||||||||||||||||||||||||||
| Life Insurance in-force, net of reinsurance | $30,886 | $31,603 | $31,915 | $32,026 | $31,926 | |||||||||||||||||||||||||||

| Financial Supplement | 12 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| Adjusted revenues | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Premiums | $— | $— | $— | $2 | $— | $— | $— | |||||||||||||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 88 | 87 | 85 | 90 | 88 | 88 | 88 | |||||||||||||||||||||||||||||||||||||
| Net investment income | 268 | 305 | 292 | 283 | 272 | 268 | 272 | |||||||||||||||||||||||||||||||||||||
| Other revenues | 7 | 6 | 8 | 7 | 7 | 7 | 7 | |||||||||||||||||||||||||||||||||||||
| Total adjusted revenues | $363 | $398 | $385 | $382 | $367 | $363 | $367 | |||||||||||||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $343 | $392 | $(519) | $400 | $352 | $343 | $352 | |||||||||||||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 53 | 56 | 61 | 58 | 60 | 53 | 60 | |||||||||||||||||||||||||||||||||||||
| Amortization of DAC and VOBA | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Other operating costs | 28 | 31 | 32 | 29 | 36 | 28 | 36 | |||||||||||||||||||||||||||||||||||||
| Total adjusted expenses | 424 | 479 | (426) | 487 | 448 | 424 | 448 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) before provision for income tax | (61) | (81) | 811 | (105) | (81) | (61) | (81) | |||||||||||||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | (13) | (23) | 170 | (22) | (17) | (13) | (17) | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) | $(48) | $(58) | $641 | $(83) | $(64) | $(48) | $(64) | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | 13 | |||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| UNIVERSAL LIFE WITH SECONDARY GUARANTEES ACCOUNT VALUE | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Account value, beginning of period | $4,461 | $4,548 | $4,619 | $4,710 | $4,779 | |||||||||||||||||||||||||||
| Premiums and deposits (1) | 152 | 145 | 146 | 156 | 157 | |||||||||||||||||||||||||||
| Withdrawals, surrenders and contract benefits | (26) | (34) | (20) | (42) | (20) | |||||||||||||||||||||||||||
| Net flows | 126 | 111 | 126 | 114 | 137 | |||||||||||||||||||||||||||
| Interest credited | 37 | 39 | 39 | 39 | 40 | |||||||||||||||||||||||||||
| Policy charges and other | (236) | (237) | (236) | (244) | (246) | |||||||||||||||||||||||||||
| Account value, end of period | $4,388 | $4,461 | $4,548 | $4,619 | $4,710 | |||||||||||||||||||||||||||
| As of | ||||||||||||||||||||||||||||||||
| LIFE INSURANCE IN-FORCE | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Universal Life with Secondary Guarantees | ||||||||||||||||||||||||||||||||
| Life Insurance in-force, before reinsurance | $65,867 | $66,293 | $66,904 | $67,445 | $68,039 | |||||||||||||||||||||||||||
| Life Insurance in-force, net of reinsurance | $31,867 | $32,190 | $32,556 | $32,879 | $33,212 | |||||||||||||||||||||||||||
| (1) Includes premiums and deposits directed to the general account investment option of variable products. | ||||||||||||||||||||||||||||||||

| Financial Supplement | 14 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| Adjusted revenues | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Premiums | $— | $— | $— | $— | $— | $— | $— | |||||||||||||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Net investment income | 131 | 142 | 148 | 155 | 159 | 131 | 159 | |||||||||||||||||||||||||||||||||||||
| Other revenues | 1 | 2 | 5 | 3 | (5) | 1 | (5) | |||||||||||||||||||||||||||||||||||||
| Total adjusted revenues | $132 | $144 | $153 | $158 | $154 | $132 | $154 | |||||||||||||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $— | $— | $— | $— | $— | $— | $— | |||||||||||||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 90 | 97 | 103 | 103 | 106 | 90 | 106 | |||||||||||||||||||||||||||||||||||||
| Amortization of DAC and VOBA | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Interest expense on debt | 38 | 38 | 38 | 38 | 38 | 38 | 38 | |||||||||||||||||||||||||||||||||||||
| Other operating costs | 15 | 44 | 8 | 20 | 11 | 15 | 11 | |||||||||||||||||||||||||||||||||||||
| Total adjusted expenses | 143 | 179 | 149 | 161 | 155 | 143 | 155 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings before provision for income tax | (11) | (35) | 4 | (3) | (1) | (11) | (1) | |||||||||||||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | (8) | (11) | (9) | (3) | (5) | (8) | (5) | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) after provision for income tax | (3) | (24) | 13 | — | 4 | (3) | 4 | |||||||||||||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | 2 | 1 | 2 | — | 2 | 2 | 2 | |||||||||||||||||||||||||||||||||||||
| Less: Preferred stock dividends | 26 | 25 | 26 | 25 | 26 | 26 | 26 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) | $(31) | $(50) | $(15) | $(25) | $(24) | $(31) | $(24) | |||||||||||||||||||||||||||||||||||||
INSTITUTIONAL SPREAD MARGIN BUSINESS ACCOUNT BALANCE | ||||||||||||||||||||||||||||||||||||||||||||
Institutional spread margin business account balance, end of period | $9,328 | $9,477 | $9,850 | $10,149 | $10,092 | |||||||||||||||||||||||||||||||||||||||


| Financial Supplement | 16 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| CHANGE IN MARKET RISK BENEFITS | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Market risk benefits mark-to-market | $(835) | $205 | $(424) | $1,020 | $(999) | $(835) | $(999) | |||||||||||||||||||||||||||||||||||||
| Market risk benefits fees, net of claims | 75 | 151 | 136 | 97 | 95 | 75 | 95 | |||||||||||||||||||||||||||||||||||||
| Ceded reinsurance | 12 | (7) | (1) | (16) | 11 | 12 | 11 | |||||||||||||||||||||||||||||||||||||
| Total change in market risk benefits | $(748) | $349 | $(289) | $1,101 | $(893) | $(748) | $(893) | |||||||||||||||||||||||||||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| NET DERIVATIVE GAINS (LOSSES) | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Net derivative gains (losses): | ||||||||||||||||||||||||||||||||||||||||||||
| Variable annuity and Shield hedges | $(1,327) | $(12) | $1,310 | $1,073 | $(877) | $(1,327) | $(877) | |||||||||||||||||||||||||||||||||||||
| Shield embedded derivatives | 805 | (354) | (1,694) | (2,103) | 1,171 | 805 | 1,171 | |||||||||||||||||||||||||||||||||||||
| ULSG hedges | (8) | (69) | (10) | (154) | 22 | (8) | 22 | |||||||||||||||||||||||||||||||||||||
| Other hedges and embedded derivatives | 21 | (20) | (16) | (54) | (5) | 21 | (5) | |||||||||||||||||||||||||||||||||||||
| Subtotal | (509) | (455) | (410) | (1,238) | 311 | (509) | 311 | |||||||||||||||||||||||||||||||||||||
| Investment hedge adjustments | — | (1) | — | 1 | — | — | — | |||||||||||||||||||||||||||||||||||||
| Total net derivative gains (losses) | $(509) | $(456) | $(410) | $(1,237) | $311 | $(509) | $311 | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | 17 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Actuarial items and other insurance adjustments | $12 | $13 | $(709) | $— | $10 | $12 | $10 | |||||||||||||||||||||||||||||||||||||
| Total notable items (1) | $12 | $13 | $(709) | $— | $10 | $12 | $10 | |||||||||||||||||||||||||||||||||||||
| NOTABLE ITEMS BY SEGMENT | ||||||||||||||||||||||||||||||||||||||||||||
| Annuities | $— | $— | $7 | $— | $10 | $— | $10 | |||||||||||||||||||||||||||||||||||||
| Life | (5) | 6 | (11) | — | — | (5) | — | |||||||||||||||||||||||||||||||||||||
| Run-off | 17 | 7 | (705) | — | — | 17 | — | |||||||||||||||||||||||||||||||||||||
| Corporate & Other | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Total notable items (1) | $12 | $13 | $(709) | $— | $10 | $12 | $10 | |||||||||||||||||||||||||||||||||||||
| (1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||||||||

| Financial Supplement | 18 | |||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| VARIABLE ANNUITY SEPARATE ACCOUNT RETURNS | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Total Quarterly VA separate account gross returns | (1.84)% | 2.14% | 4.96% | 7.59% | (0.54)% | |||||||||||||||||||||||||||
| TOTAL VARIABLE ANNUITY SEPARATE ACCOUNT ALLOCATIONS | ||||||||||||||||||||||||||||||||
| Percent allocated to equity funds | 31.81% | 32.56% | 32.61% | 32.54% | 31.28% | |||||||||||||||||||||||||||
| Percent allocated to bond funds/other funds | 9.50% | 9.20% | 9.13% | 9.04% | 9.58% | |||||||||||||||||||||||||||
| Percent allocated to target volatility funds | 18.14% | 17.77% | 17.85% | 17.81% | 18.41% | |||||||||||||||||||||||||||
| Percent allocated to balanced funds | 40.55% | 40.47% | 40.41% | 40.61% | 40.73% | |||||||||||||||||||||||||||

| Financial Supplement | 19 | |||||||||||||
| March 31, 2026 | December 31, 2025 | |||||||||||||||||||||||||
| Amount | % of Total | Amount | % of Total | |||||||||||||||||||||||
| Fixed maturity securities: | ||||||||||||||||||||||||||
| U.S. corporate securities | $38,336 | 30.34% | $38,909 | 30.88% | ||||||||||||||||||||||
| Foreign corporate securities | 11,103 | 8.79% | 11,497 | 9.12% | ||||||||||||||||||||||
| Residential mortgage-backed securities | 8,879 | 7.03% | 8,532 | 6.77% | ||||||||||||||||||||||
| U.S. government and agency securities | 6,663 | 5.27% | 6,711 | 5.32% | ||||||||||||||||||||||
| Asset-backed securities | 6,102 | 4.83% | 6,059 | 4.81% | ||||||||||||||||||||||
| Commercial mortgage-backed securities | 5,840 | 4.62% | 5,870 | 4.66% | ||||||||||||||||||||||
| State and political subdivision securities | 3,414 | 2.70% | 3,494 | 2.77% | ||||||||||||||||||||||
| Foreign government securities | 895 | 0.71% | 942 | 0.75% | ||||||||||||||||||||||
| Total fixed maturity securities | 81,232 | 64.29% | 82,014 | 65.08% | ||||||||||||||||||||||
| Trading securities | 544 | 0.43% | 506 | 0.40% | ||||||||||||||||||||||
| Equity securities | 76 | 0.06% | 79 | 0.06% | ||||||||||||||||||||||
| Mortgage loans: | ||||||||||||||||||||||||||
| Commercial mortgage loans | 12,134 | 9.60% | 12,323 | 9.78% | ||||||||||||||||||||||
| Residential mortgage loans | 6,052 | 4.79% | 5,976 | 4.74% | ||||||||||||||||||||||
| Agricultural mortgage loans | 4,644 | 3.68% | 4,656 | 3.70% | ||||||||||||||||||||||
| Allowance for credit losses | (210) | (0.17)% | (200) | (0.16)% | ||||||||||||||||||||||
| Total mortgage loans, net | 22,620 | 17.90% | 22,755 | 18.06% | ||||||||||||||||||||||
| Policy loans | 1,458 | 1.15% | 1,450 | 1.15% | ||||||||||||||||||||||
| Limited partnerships and limited liability companies | 4,673 | 3.70% | 4,696 | 3.73% | ||||||||||||||||||||||
| Cash, cash equivalents and short-term investments | 6,143 | 4.86% | 6,584 | 5.22% | ||||||||||||||||||||||
| Other invested assets: | ||||||||||||||||||||||||||
| Derivatives: | ||||||||||||||||||||||||||
| Equity market | 7,715 | 6.11% | 6,121 | 4.86% | ||||||||||||||||||||||
| Interest rate | 278 | 0.22% | 297 | 0.23% | ||||||||||||||||||||||
| Foreign currency exchange rate | 436 | 0.35% | 350 | 0.28% | ||||||||||||||||||||||
| Credit | 19 | 0.01% | 11 | 0.01% | ||||||||||||||||||||||
| Total derivatives | 8,448 | 6.69% | 6,779 | 5.38% | ||||||||||||||||||||||
| ICOLI | 837 | 0.66% | 822 | 0.65% | ||||||||||||||||||||||
| FHLB common stock | 217 | 0.17% | 217 | 0.17% | ||||||||||||||||||||||
| Other | 115 | 0.09% | 114 | 0.10% | ||||||||||||||||||||||
| Total other invested assets | 9,617 | 7.61% | 7,932 | 6.30% | ||||||||||||||||||||||
| Total investments and cash and cash equivalents | $126,363 | 100.00% | $126,016 | 100.00% | ||||||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | ||||||||||||||||||||||||||||
Adjusted net investment income yield (1) | 4.24% | 4.44% | 4.40% | 4.28% | 4.25% | |||||||||||||||||||||||||||
| (1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||

| Financial Supplement | 20 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| COMBINED REVENUES AND EXPENSES (1) | PRELIMINARY March 31, 2026 (2) | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | PRELIMINARY March 31, 2026 (2) | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Total revenues (Line 9) | $5,000 | $3,002 | $2,293 | $1,455 | $4,809 | $5,000 | $4,809 | |||||||||||||||||||||||||||||||||||||
Total benefits and expenses before dividends to policyholders (Line 28) | $3,600 | $2,919 | $3,679 | $2,360 | $3,584 | $3,600 | $3,584 | |||||||||||||||||||||||||||||||||||||
COMBINED NET INCOME (LOSS) (1), (3) | ||||||||||||||||||||||||||||||||||||||||||||
Gain (loss) from operations net of taxes and dividends to policyholders (Line 33) | $1,400 | $122 | $(1,333) | $(921) | $1,225 | $1,400 | $1,225 | |||||||||||||||||||||||||||||||||||||
Net realized capital gains (losses), net of taxes and certain transfers to interest maintenance reserve (Line 34) | (500) | (434) | 599 | (643) | (784) | (500) | (784) | |||||||||||||||||||||||||||||||||||||
Net income (loss) (Line 35) | $900 | $(312) | $(734) | $(1,564) | $441 | $900 | $441 | |||||||||||||||||||||||||||||||||||||
COMBINED CHANGE IN NET UNREALIZED GAIN (LOSS) (3), (4) | ||||||||||||||||||||||||||||||||||||||||||||
| Change in net unrealized gain (loss) recorded in surplus, net of tax (Lines 38, 39, 46 & 47) | $(1,000) | $133 | $508 | $1,414 | $(119) | $(1,000) | $(119) | |||||||||||||||||||||||||||||||||||||
| (1) Combined statutory results are for Brighthouse Life Insurance Company, Brighthouse Life Insurance Company of NY and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||||||||
(2) Reflects preliminary statutory results for the three months ended March 31, 2026. | ||||||||||||||||||||||||||||||||||||||||||||
(3) Combined net income (loss) and combined change in net unrealized gain (loss) should be considered in aggregate for a more complete understanding of our business, including realized and unrealized gains (losses) associated with our variable annuities and Shield hedges and other equity risk management strategies. | ||||||||||||||||||||||||||||||||||||||||||||
(4) Combined statutory results are for Brighthouse Life Insurance Company and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||||||||

| Financial Supplement | 21 | |||||||||||||
| As of | ||||||||||||||||||||||||||||||||||||||
| COMBINED ASSETS, LIABILITIES, AND CAPITAL AND SURPLUS (1) | PRELIMINARY March 31, 2026 (2) | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||||||||
Total assets (Line 28) | $197,000 | $201,005 | $203,382 | $202,943 | $193,978 | |||||||||||||||||||||||||||||||||
| Total liabilities (Line 28) | $193,500 | $197,152 | $199,492 | $198,900 | $189,859 | |||||||||||||||||||||||||||||||||
Total capital and surplus (Line 38) | $3,500 | $3,853 | $3,890 | $4,043 | $4,119 | |||||||||||||||||||||||||||||||||
COMBINED TAC AND RBC RATIO (1), (3) | ||||||||||||||||||||||||||||||||||||||
Combined total adjusted capital | $5,000 | $5,328 | $5,400 | $5,560 | $5,549 | |||||||||||||||||||||||||||||||||
Combined risk-based capital ratio (4) | 430%-450% | 456% | 435%-455% | 405%-425% | 420%-440% | |||||||||||||||||||||||||||||||||
DIVIDENDS PAID TO HOLDING COMPANY (1), (3) | ||||||||||||||||||||||||||||||||||||||
| Total dividends paid | $— | $— | $— | $— | $— | |||||||||||||||||||||||||||||||||
| (1) Combined statutory results are for Brighthouse Life Insurance Company and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||
(2) Reflects preliminary statutory results as of March 31, 2026. | ||||||||||||||||||||||||||||||||||||||
(3) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||
(4) The RBC ratio is reported as a preliminary range for all periods, except those ended December 31. | ||||||||||||||||||||||||||||||||||||||


| Financial Supplement | A-1 | |||||||||||||

| Financial Supplement | A-2 | |||||||||||||
| Non-GAAP financial measures: | Most directly comparable GAAP financial measures: | |||||||||||||
| (i) | adjusted earnings | (i) | net income (loss) available to shareholders (1) | |||||||||||
| (ii) | adjusted earnings, less notable items | (ii) | net income (loss) available to shareholders (1) | |||||||||||
| (iii) | adjusted revenues | (iii) | revenues | |||||||||||
| (iv) | adjusted expenses | (iv) | expenses | |||||||||||
| (v) | adjusted earnings per common share | (v) | earnings per common share, diluted (1) | |||||||||||
| (vi) | adjusted earnings per common share, less notable items | (vi) | earnings per common share, diluted (1) | |||||||||||
| (vii) | adjusted return on common equity | (vii) | return on common equity (2) | |||||||||||
| (viii) | adjusted return on common equity, less notable items | (viii) | return on common equity (2) | |||||||||||
| (ix) | adjusted net investment income | (ix) | net investment income | |||||||||||
(x) | adjusted net investment income yield | (x) | net investment income yield | |||||||||||
| __________________ | ||||||||||||||
(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.’s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share. | ||||||||||||||
(2) Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.’s common stockholders' equity. | ||||||||||||||

| Financial Supplement | A-3 | |||||||||||||

| Financial Supplement | A-4 | |||||||||||||

| Financial Supplement | A-5 | |||||||||||||

| Financial Supplement | A-6 | |||||||||||||
| AOCI | Accumulated other comprehensive income (loss) | ||||
| DAC | Deferred policy acquisition costs | ||||
| FHLB | Federal Home Loan Bank | ||||
| GAAP | Accounting principles generally accepted in the United States of America | ||||
| GMDB | Guaranteed minimum death benefits | ||||
| GMIB | Guaranteed minimum income benefits | ||||
| GMWB | Guaranteed minimum withdrawal benefits | ||||
| ICOLI | Insurance company-owned life insurance | ||||
| NDGL | Net derivative gains (losses) | ||||
| NIGL | Net investment gains (losses) | ||||
| RBC | Risk-based capital | ||||
| TAC | Total adjusted capital | ||||
| ULSG | Universal life insurance with secondary guarantees | ||||
| VA | Variable annuity | ||||
| VOBA | Value of business acquired | ||||

| Financial Supplement | A-7 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| ADJUSTED EARNINGS, LESS NOTABLE ITEMS (1) | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders | $(792) | $112 | $453 | $60 | $(294) | $(792) | $(294) | |||||||||||||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (52) | (23) | 48 | (39) | (83) | (52) | (83) | |||||||||||||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (10) | (7) | 7 | (6) | 6 | (10) | 6 | |||||||||||||||||||||||||||||||||||||
| Less: Net derivative gains (losses), excluding investment hedge adjustments | (509) | (455) | (410) | (1,238) | 311 | (509) | 311 | |||||||||||||||||||||||||||||||||||||
| Less: Change in market risk benefits | (748) | 349 | (289) | 1,101 | (893) | (748) | (893) | |||||||||||||||||||||||||||||||||||||
| Less: Market value adjustments | 13 | 6 | (10) | 6 | (10) | 13 | (10) | |||||||||||||||||||||||||||||||||||||
| Less: Provision for income tax (expense) benefit on reconciling adjustments | 275 | 28 | 137 | 38 | 140 | 275 | 140 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) | 239 | 214 | 970 | 198 | 235 | 239 | 235 | |||||||||||||||||||||||||||||||||||||
| Less: Notable items | (12) | (13) | 709 | — | (10) | (12) | (10) | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items | $251 | $227 | $261 | $198 | $245 | $251 | $245 | |||||||||||||||||||||||||||||||||||||
| ADJUSTED EARNINGS, LESS NOTABLE ITEMS PER COMMON SHARE (1), (2) | ||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders per common share | $(13.82) | $1.93 | $7.89 | $1.02 | $(5.04) | $(13.82) | $(5.04) | |||||||||||||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (0.91) | (0.40) | 0.83 | (0.68) | (1.42) | (0.91) | (1.42) | |||||||||||||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (0.17) | (0.12) | 0.12 | (0.10) | 0.10 | (0.17) | 0.10 | |||||||||||||||||||||||||||||||||||||
| Less: Net derivative gains (losses), excluding investment hedge adjustments | (8.88) | (7.87) | (7.13) | (21.44) | 5.34 | (8.88) | 5.34 | |||||||||||||||||||||||||||||||||||||
| Less: Change in market risk benefits | (13.05) | 6.04 | (5.02) | 19.07 | (15.33) | (13.05) | (15.33) | |||||||||||||||||||||||||||||||||||||
| Less: Market value adjustments | 0.23 | 0.10 | (0.17) | 0.10 | (0.17) | 0.23 | (0.17) | |||||||||||||||||||||||||||||||||||||
| Less: Provision for income tax (expense) benefit on reconciling adjustments | 4.80 | 0.48 | 2.38 | 0.66 | 2.40 | 4.80 | 2.40 | |||||||||||||||||||||||||||||||||||||
| Less: Impact of inclusion of dilutive shares | 0.03 | — | — | — | 0.03 | 0.03 | 0.03 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) per common share | 4.15 | 3.70 | 16.87 | 3.43 | 4.01 | 4.15 | 4.01 | |||||||||||||||||||||||||||||||||||||
Less: Notable items | (0.21) | (0.22) | 12.33 | — | (0.17) | (0.21) | (0.17) | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items per common share | $4.35 | $3.93 | $4.54 | $3.43 | $4.17 | $4.35 | $4.17 | |||||||||||||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in this Appendix. | ||||||||||||||||||||||||||||||||||||||||||||
| (2) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. | ||||||||||||||||||||||||||||||||||||||||||||

| Financial Supplement | A-8 | |||||||||||||
| Four Quarters Cumulative Trailing Basis | ||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Net income (loss) available to shareholders | $(167) | $331 | $865 | $562 | $511 | |||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (66) | (97) | (147) | (255) | (336) | |||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (16) | — | 7 | — | 6 | |||||||||||||||||||||||||||
| Less: Net derivative gains (losses), excluding investment hedge adjustments | (2,612) | (1,792) | (2,332) | (2,021) | (1,454) | |||||||||||||||||||||||||||
| Less: Change in market risk benefits | 413 | 268 | 1,406 | 1,085 | 340 | |||||||||||||||||||||||||||
| Less: Market value adjustments | 15 | (8) | — | (1) | (1) | |||||||||||||||||||||||||||
| Less: Provision for income tax (expense) benefit on reconciling adjustments | 478 | 343 | 224 | 250 | 304 | |||||||||||||||||||||||||||
| Adjusted earnings | $1,621 | $1,617 | $1,707 | $1,504 | $1,652 | |||||||||||||||||||||||||||
| Five Quarters Average Stockholders' Equity Basis | ||||||||||||||||||||||||||||||||
BRIGHTHOUSE FINANCIAL, INC.’S COMMON STOCKHOLDERS’ EQUITY, EXCLUDING AOCI | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s stockholders’ equity | $5,921 | $5,800 | $5,552 | $5,107 | $4,812 | |||||||||||||||||||||||||||
| Less: Preferred stock, net | 1,699 | 1,699 | 1,699 | 1,699 | 1,699 | |||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s common stockholders’ equity | 4,222 | 4,101 | 3,853 | 3,408 | 3,113 | |||||||||||||||||||||||||||
| Less: AOCI | (4,166) | (4,391) | (4,470) | (4,750) | (4,981) | |||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI | $8,388 | $8,492 | $8,323 | $8,158 | $8,094 | |||||||||||||||||||||||||||
| Five Quarters Average Common Stockholders' Equity Basis | ||||||||||||||||||||||||||||||||
ADJUSTED RETURN ON COMMON EQUITY, EXCLUDING AOCI | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Return on common equity | (4.0)% | 8.1% | 22.5% | 16.5% | 16.4% | |||||||||||||||||||||||||||
| Return on AOCI | 4.0% | (7.5)% | (19.4)% | (11.8)% | (10.3)% | |||||||||||||||||||||||||||
| Return on common equity, excluding AOCI | (2.0)% | 3.9% | 10.4% | 6.9% | 6.3% | |||||||||||||||||||||||||||
| Less: Return on net investment gains (losses) | (0.8)% | (1.1)% | (1.8)% | (3.1)% | (4.2)% | |||||||||||||||||||||||||||
| Less: Return on investment gains (losses) on trading securities | (0.2)% | —% | 0.1% | —% | 0.1% | |||||||||||||||||||||||||||
| Less: Return on net derivative gains (losses), excluding investment hedge adjustments | (31.1)% | (21.1)% | (28.0)% | (24.8)% | (18.0)% | |||||||||||||||||||||||||||
| Less: Return on change in market risk benefits | 4.9% | 3.2% | 16.9% | 13.3% | 4.2% | |||||||||||||||||||||||||||
| Less: Return on market value adjustments | 0.2% | (0.1)% | —% | —% | —% | |||||||||||||||||||||||||||
| Less: Return on provision for income tax (expense) benefit on reconciling adjustments | 5.7% | 4.0% | 2.7% | 3.1% | 3.8% | |||||||||||||||||||||||||||
| Adjusted return on common equity, excluding AOCI | 19.3% | 19.0% | 20.5% | 18.4% | 20.4% | |||||||||||||||||||||||||||

| Financial Supplement | A-9 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | ||||||||||||||||||||||||||||||||||||||
| Total revenues | $1,527 | $1,689 | $1,816 | $871 | $2,390 | $1,527 | $2,390 | |||||||||||||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (52) | (23) | 48 | (39) | (83) | (52) | (83) | |||||||||||||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (10) | (7) | 7 | (6) | 6 | (10) | 6 | |||||||||||||||||||||||||||||||||||||
| Less: Net derivative gains (losses) | (509) | (456) | (410) | (1,237) | 311 | (509) | 311 | |||||||||||||||||||||||||||||||||||||
| Less: Investment hedge adjustments | — | 1 | — | (1) | — | — | — | |||||||||||||||||||||||||||||||||||||
| Total adjusted revenues | $2,098 | $2,174 | $2,171 | $2,154 | $2,156 | $2,098 | $2,156 | |||||||||||||||||||||||||||||||||||||
| Total expenses | $2,513 | $1,539 | $1,231 | $778 | $2,744 | $2,513 | $2,744 | |||||||||||||||||||||||||||||||||||||
| Less: Change in market risk benefits | 748 | (349) | 289 | (1,101) | 893 | 748 | 893 | |||||||||||||||||||||||||||||||||||||
| Less: Market value adjustments | (13) | (6) | 10 | (6) | 10 | (13) | 10 | |||||||||||||||||||||||||||||||||||||
| Total adjusted expenses | $1,778 | $1,894 | $932 | $1,885 | $1,841 | $1,778 | $1,841 | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | A-10 | |||||||||||||
| For the Three Months Ended | For the Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||
| NET INVESTMENT GAINS (LOSSES) | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 | |||||||||||||||||||||||||||||||||||||
| Investment portfolio gains (losses) | $(26) | $(14) | $52 | $(5) | $(31) | $(26) | $(31) | |||||||||||||||||||||||||||||||||||||
| Investment portfolio credit loss (provision) release and (writedowns) | (26) | (9) | (4) | (34) | (52) | (26) | (52) | |||||||||||||||||||||||||||||||||||||
| Net investment gains (losses) | $(52) | $(23) | $48 | $(39) | $(83) | $(52) | $(83) | |||||||||||||||||||||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| ADJUSTED NET INVESTMENT INCOME YIELD (1) | March 31, 2026 | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | |||||||||||||||||||||||||||
| Investment income yield | 4.39% | 4.60% | 4.54% | 4.41% | 4.39% | |||||||||||||||||||||||||||
| Investment fees and expenses | (0.15)% | (0.16)% | (0.14)% | (0.13)% | (0.14)% | |||||||||||||||||||||||||||
| Adjusted net investment income yield | 4.24% | 4.44% | 4.40% | 4.28% | 4.25% | |||||||||||||||||||||||||||
| (1) See definitions for Non-GAAP and Other Financial Disclosures in this Appendix. | ||||||||||||||||||||||||||||||||

